Key result
Plasma plasmin-alpha 2PI complex falls ~76% upon DIC remission.
Observational (n=48)
Answers are grounded in this paper and cite their sources.
Plasmin-alpha 2-plasmin inhibitor (alpha 2PI) complex, an indicator of in vivo plasmin generation, was measured in the plasma of 48 patients with disseminated intravascular coagulation (DIC), by enzyme-linked immunosorbent assay (ELISA). Plasmin-alpha 2PI complex was markedly elevated to 7.9 +/- 4.26 mg/liter (mean +/- SD) in DIC at presentation, with normal values at less than 0.8 mg/liter. The concentration of plasmin-alpha 2PI complex changed in parallel with the course of DIC and decreased to 1.9 +/- 1.49 mg/liter (n = 28) in remission. Among various underlying disorders, DIC, in patients with acute promyelocytic leukemia, had the highest complex levels (mean 10.8 mg/liter), and septic patients had the lowest levels (mean 3.4 mg/liter). No significant correlation was found between FDP and plasmin-alpha 2PI complex. These results indicate that the quantitative assay of plasmin-alpha 2PI complex in plasma would be valuable in the assessment of hyperfibrinolysis in DIC.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (1988) conducted an observational in Disseminated intravascular coagulation (DIC) (n=48). Plasmin-alpha 2-plasmin inhibitor (alpha 2PI) complex ELISA assay vs. Normal reference values (<0.8 mg/liter) and remission state was evaluated on Plasma plasmin-alpha 2PI complex concentration (mg/liter). Plasma plasmin-alpha 2PI complex was markedly elevated in DIC at presentation and decreased to 1.9 +/- /L in remission.
Synapse has enriched 10 related papers. Consider them for comparative context: